Excessive adipose tissue, particularly with a central distribution, consists of visceral fat, which is metabolically active and could impinge upon central nervous system functioning. The aim of the current study was to examine levels of visceral adiposity in relation to key cerebral metabolite ratios localized in the occipitoparietal grey matter. Seventy-three adults, aged between 40 and 60 years, underwent structural magnetic resonance imaging and single voxel 1H Magnetic Resonance Spectroscopy (1H MRS). Visceral fat was assessed using Dual Energy X Ray Absorptiometry (DXA). Individuals with higher visceral fat mass and volume had significantly lower ratios of N-acetyl-aspartate to total creatine (phosphocreatine + creatine, PCr + Cr) (NAA/PCr + Cr) (β = -0.29, p = 0.03, β = -0.28, p = 0.04). They also had significantly higher ratios of myo-inositol to total creatine (mI/PCr + Cr ) (β = 0.36, p = 0.01, β = 0.36, p = 0.01). Visceral fat mass and volume were not significantly related to ratios of glutamate to total creatine (Glu/PCr + Cr). While future studies are necessary, these results indicate central adiposity is associated with metabolic changes that could impinge upon the central nervous system in middle age.

Department of Kinesiology and Health Education The University of Texas at Austin Austin TX USA

Department of Psychology The University of Texas at Austin 108 East Dean Keeton Stop A8000 Austin TX 78712 USA

Imaging Research Center The University of Texas at Austin Austin TX USA

International Clinical Research Center St Anne's University Hospital Brno Czech Republic

Zobrazit více v PubMed

Brand A, Richter-Landsburg C; Leibfritz D (1993). Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental Neuroscience 15, 289–298. PubMed

Bruno JL, Shelly EW; Quintin E-M; Rostami M; Patnaik S; Spielman D; et al. (2013). Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study. Journal of Neurodevelopmental Disorders 5, 20. PubMed PMC

Cereda E, Sansone V, Meola G & Malavazos AE (2007). Increased visceral adipose tissue rather than BMI as a risk factor for dementia. Age Ageing 36, 488–91. PubMed

Chen SQ, Wang PJ, Ten GJ, Zhan W; Li MH, et al. (2010). Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer’s Disease in APP/PS1 Transgenic Mice. Dementia and Geriatric Cognitive Disorders 28, 558–566. PubMed PMC

Cloak CC; Chang L; Ernst T (2004). Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. Journal of neuroimmunology 157, 147–152. PubMed

Curtis JP; Selter JG; Wang Y; Rathore SS; Jovin IS; Jadbabaie F; Kosiborod M,; Portnay EL; Sokol SI; Bader F; Krumholz HM (2005). The obesity paradox: Body Mass Index and Outcomes in Patients with Heart Failure. Journal of The American Medical Association Internal Medicine 165, 55–61. PubMed

de Luca C, Olefsky JM (2008). Inflammation and insulin resistance. Federation of European Biochemical Societies Letters 582, 97–105. PubMed PMC

Eagan DE, Gonzales MM, Tarumi T, Tanaka H, Stautberg S, Haley AP (2012). Elevated serum C-Reactive Protein relates to increased cerebral myoinositol levels in middle aged adults. Cardiovascular Psychiatry and Neurology 2012, 1–9. PubMed PMC

Fayed N; Andres E; Viguera L; Modrego PJ; Garcia-Campayo J (2014). Higher glutamate + glutamine and reduction of N-Acetylaspartate in Posterior Cingulate according to age range in patients with cognitive impairment and/or pain. Academic Radiology 21, 1211–1217. PubMed

Fernando KT; Mclean MA; Chard DT; MacManus DG; Dalton CM; Miszkiel MA; et al. (2004). Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127, 1361–1369. PubMed

Filley CM, Brown MS; Onderko K; Ray M; Bennett RE; Berry-Kravis E; et al. (2015). White matter disease and cognitive impairment in FMR1 premutation carriers. Neurology. PubMed PMC

Gazdzinski S; Millin R; Kaiser LG; Durazzo TC; Mueller SG; Weiner MW; et al. (2010). BMI and neuronal integrity in healthy, cognitively normal elderly: A proton magnetic resonance spectroscopy study. Obesity (Silver Spring) 18, 743–748. PubMed PMC

Gonzales MM, Kaur S, Eagan DE, Goudarzi K, Pasha E, Doan DC, Tanaka H & Haley AP (2014). Central adiposity and the functional magnetic resonance imaging response to cognitive challenge. International Journal of Obesity (Lond). PubMed PMC

Gonzales MM, Takashi T, Eagan DE, Tanaka H, Vaghasia M, Haley AP (2012). Indirect Effects of Elevated Body Mass Index on Memory Performance Through Altered Cerebral Metabolite Concentrations. Psychosomatic Medicine 74, 691–698. PubMed PMC

Grachev ID; Kumar R; Ramachandran TS; Szevereny NM (2001). Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: an in vivo (1)H-MRS study of the Stroop Color-Word task. Molecular Psychiatry 6, 529–539. PubMed

Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I (2003). An 18-year follow up of overweight and risk of Alzheimer Disease. Archives of Internal Medicine 163, 1524–1528. PubMed

Gustafson DR (2010). Adiposity hormones and dementia. Journal of Neurological Science 299, 30–4. PubMed

Haley AP; Gonzales MM; Tarumi T; Tanaka H (2013). Dyslipidemia links obesity to early cerebral neurochemical alterations. Obesity 21, 2007–2013. PubMed PMC

Hattingen E; Raab P; Franz K; Zanella FE; Lanfermann H; Pilatus U (2007). Myo-Inositol: a marker of reactive astrogliosis in glial tumors. NMR in biomedicine 21, 233–241. PubMed

Huang W, Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapopport SI et al. (1999). High brain myo-inositol levels in the predementia phase of Alzheimer’s disease in adults with Down’s syndrome: a 1H MRS study. American Journal of Psychiatry 156, 1876–1886. PubMed

Isaac V, Sim Sam, Zheng Hui, Zagorodnov V, Tai ES, Chee M (2011). Adverse associations between visceral adiposity, brain structure and cognitive performance in healthy elderly. Frontiers in Aging Neuroscience 3. PubMed PMC

Jessen F; Block W; Traber F; Keller E; Flacke S; et al. (2001). Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 57, 930–932. PubMed

Kantarci K; Jack CR; Campeau NG; O’Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG et al. (2000). Regional metabolic patterns in mild cognitive impairment and Alzheimer’s Disease: a H MRS study. Neurology 55, 210–217. PubMed PMC

Kaur S, Gonzales M, Strasser B, Pasha E, McNeely J, Tanaka H, Haley AP (2015) Central adiposity & cortical thickness in midlife, Psychosomatic Medicine 77, 671–678 PubMed

Kernie SG, Leibl D, Parada lf (2000). BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19, 1290–1300. PubMed PMC

Kerwin DR, Gaussoin SA, Chlebowski RT, Kuller LH, Vitolins M, Coker LH et al. (2011). Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the Women’s Health Initiative Memory Study. Journal of the American Geriatric Society 59, 107–12. PubMed

Kopelman P (2000). Obesity as a medical problem. Nature 404, 635–643. PubMed

Pan W; Kastin AJ (2007). Adipokines and the blood-brain barrier. Peptides 28, 1317–1330. PubMed PMC

Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30, 672–679. PubMed

Qizilibash N; Gregson J; Johnson ME; Pearce N,; Douglas I; Wing K; et al. (2015). BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinology. PubMed

Ross AJ; Sachdev PS; Wen W; Brodaty H; Joscelyn A; Lorentz LMm (2006). Prediction of cognitive decline after stroke using proton magnetic resonance spectroscopy. Journal of the Neurological Sciences 251, 62–69. PubMed

Ross AJ; Sachdev PS; Wen W; Valenzuela MJ, Brodaty H (2005). Cognitive correlates of H MRS measures in the healthy elderly brain. Brain Research Bulletin 66, 9–16. PubMed

Serrano-Pozo AMM, Gomez-Isla T, Betensky RA, Growdon JH, Frosch MP, Hyman BT (2011). Reactive glia not only associates with plaques but also parallels tangles in Alzheimer’s Disease. The American Journal of Pathology 179, 1373–1384. PubMed PMC

Spranger J, Verma S, Gurling I, Bobbert T, Selfert J, Sindler AL, et al. (2006). Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55, 141–147. PubMed

Stern AJ; Savostyanova AA; Goldman A; Barnett AS; van der Veen JWC; Callicott JH et al. (2008). Impact of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism on levels of hippocampal N-Acetyl-Aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biological Psychiatry 64, 856–862. PubMed PMC

Urenjak J; Williams SR; Gadian DG; Noble M (1992). Specific expression of N-acetyl aspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors and immature oligodendrocytes in vitro. Journal of Neurochemistry 59, 55–61. PubMed

Warren MW, Hynan LS & Weiner MF (2012). Lipids and adipokines as risk factors for Alzheimer’s disease. Journal of Alzheimers Disease 29, 151–7. PubMed PMC

World Health Organization (2009). Global Health Risks: Mortality and burden of disease attributable to selected major risks. World Health Organization: Geneva, Switzerland.

Xia Y, Ergun DL, Wacker WK, Wang X, Davis CE, Kaul S (2014). Relationship between Dual-Energy X-Ray Apsorptiometry Volumetric Assessment and X-ray Computed Tomography-Derived Single Slice Measurement of Visceral Fat. Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health 17. PubMed

Zhang W; Wang PJ; Li MH; Wang GL; Li P; Gao ZL (2013). 1H-MRS Assessment of the therapeutic effect of bilateral intraventricular BDNF infusion into APP/PS1 double transgenic mice. Journal of Molecular Neuroscience 50, 434–442. PubMed